VIR
Vir Biotechnology Inc.
$5.74
+$0.18(+3.15%)
50
Overall
60
Value
40
Tech
--
Quality
Market Cap
$720.67M
Volume
626.72K
52W Range
$4.16 - $14.45
Target Price
$17.22
Company Overview
| Mkt Cap | $720.67M | Price | $5.74 |
| Volume | 626.72K | Change | +3.15% |
| P/E Ratio | -1.4 | Open | $5.56 |
| Revenue | $74.2M | Prev Close | $5.56 |
| Net Income | $-522.0M | 52W Range | $4.16 - $14.45 |
| Div Yield | N/A | Target | $17.22 |
| Overall | 50 | Value | 60 |
| Quality | -- | Technical | 40 |
No chart data available
Latest News
H.C. Wainwright Keeps Their Buy Rating on Vir Biotechnology (VIR)
TipRanks Auto-Generated Intelligence Newsdesk•9 hours ago
Kepler Capital Keeps Their Buy Rating on Viridien (0RI9)
TipRanks Auto-Generated Intelligence Newsdesk•a day ago
Viridien (0RI9) Receives a Buy from Kepler Capital
TipRanks Auto-Generated Intelligence Newsdesk•7 days ago
Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX) and Atea Pharmaceuticals (AVIR)
Brian Anderson•9 days ago
Barclays Sticks to Their Buy Rating for Vir Biotechnology (VIR)
TipRanks Auto-Generated Intelligence Newsdesk•10 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VIR | $5.74 | +3.1% | 626.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |